South Korea vs Least developed countries: Immunization, Hib3 (% of children ages 12-23 months)
Immunization, Hib3 (% of children ages 12-23 months) over time
- South Korea
- Least developed countries
How they compare
South Korea currently reports 97.0% against 74.4% in Least developed countries, a difference of 22.6%.
That makes South Korea's figure about 1.3 times Least developed countries's.
Across all 11 years both countries report, South Korea has been ahead every year.
South Korea ranks 29th and Least developed countries ranks 30th of 191 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Least developed countries | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.5% | 77.9% | 19.6% | South Korea |
| 2020s | 96.6% | 74.4% | 22.2% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, South Korea or Least developed countries?
- South Korea, at 97.0% against 74.4% in Least developed countries as of 2024.
- What is the difference in immunization, hib3 between South Korea and Least developed countries?
- 22.6%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Least developed countries?
- 11 years are reported by both, from 2014 to 2024.
- How do South Korea and Least developed countries rank globally for immunization, hib3?
- South Korea ranks 29th and Least developed countries ranks 30th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.